Bringing the results of research in the field of ophthalmology, which "makes the world healthy and healthy through innovation," to society
Tsubota Lab offers innovative solutions in the areas of myopia, dry eye and presbyopia. Among them, it is said that exposure to a part of sunlight (wavelength 360 to 400 nm) called violet light is effective in preventing myopia, but we have developed eyeglasses that can irradiate this (myopia prevention eyeglasses). In addition to myopia prevention, we are aiming for application in the field of keratoconus treatment and psychiatric disorders such as depression.
- Establishment Date
- February 2015
- Develop medical devices for myopia, dry eye, presbyopia, pharmaceuticals, etc.
- President and CEO Kazuo Tsubota
Point of KII view
We hope to promote science-based product development, provide truly effective products, and contribute to prevention and treatment.
KII growth support
Advice for consultation with lead managing underwriter for IPO